Dr Elizabeth L Christie

  • Peter MacCallum Cancer Institute
  • Post-Doc, Life Sciences
  • Australia

My co-authors include

Professor Daniel S. Brewer
Anna Ehinger
TaoBo Hu

My Publications

Inferring structural variant cancer cell fraction

  • Nature Communications
  • February 2020

Reconstructing evolutionary trajectories of mutation signature activities in cancer usi...

  • Nature Communications
  • February 2020

Pan-cancer analysis of whole genomes

  • Nature
  • February 2020

The evolutionary history of 2,658 cancers

  • Nature
  • February 2020

Pooled genomic screens identify anti-apoptotic genes as targetable mediators of chemoth...

  • Molecular Cancer Research
  • August 2019

TARGETING MULTIDRUG RESISTANCE PROTEIN 1 (MDR1) POTENTIATES SMAC-MIMETIC THERAPY TO KIL...

  • Experimental Hematology
  • August 2019

Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and ...

  • Nature Communications
  • March 2019

Mechanisms of Drug Resistance in High-Grade Serous Ovarian Cancer

  • Hematology/Oncology Clinics of North America
  • December 2018

Ovarian Carcinoma-Associated Mesenchymal Stem Cells Arise from Tissue-Specific Normal S...

  • Stem Cells
  • November 2018

Neutral tumor evolution?

  • Nature Genetics
  • October 2018

Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer

  • BMC Cancer
  • January 2018

Acquired chemotherapy resistance in ovarian cancer

  • Annals of Oncology
  • November 2017

Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss ...

  • Clinical Cancer Research
  • October 2017

EIF1AX and NRAS Mutations Co-occur and...

  • Cancer Research
  • June 2017

Reversion of BRCA1/2 Germline Mutations Detected in Circulating Tumor DNA From Patients...

  • Journal of Clinical Oncology
  • April 2017

Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer

  • November 2016

Blood Worth Bottling: Circulating Tumor DNA as a Cancer Biomarker

  • Cancer Research
  • October 2016

A community-based model of rapid autopsy in end-stage cancer patients

  • Nature Biotechnology
  • September 2016

Corrigendum: Whole–genome characterization of chemoresistant ovarian cancer

  • Nature
  • October 2015

Whole–genome characterization of chemoresistant ovarian cancer

  • Nature
  • May 2015

LRP1B Deletion in High-Grade Serous Ovarian Cancers Is Associated with Acquired Chemoth...

  • Cancer Research
  • August 2012

Abnormal Nuclear Pore Formation Triggers Apoptosis in the Intestinal Epithelium of elys...

  • Gastroenterology
  • March 2009

Determination of mRNA and Protein Expression Patterns in Zebrafish

  • January 2008